BI Asset Management Fondsmaeglerselskab A S Raises Stake in Xylem Inc. $XYL

BI Asset Management Fondsmaeglerselskab A S grew its stake in shares of Xylem Inc. (NYSE:XYL) by 14.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 310,469 shares of the industrial products company’s stock after purchasing an additional 40,365 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Xylem were worth $34,550,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in XYL. Fisher Asset Management LLC raised its stake in shares of Xylem by 6.4% during the third quarter. Fisher Asset Management LLC now owns 404,613 shares of the industrial products company’s stock valued at $59,681,000 after acquiring an additional 24,352 shares in the last quarter. LGT Capital Partners LTD. boosted its holdings in shares of Xylem by 18.4% in the third quarter. LGT Capital Partners LTD. now owns 268,704 shares of the industrial products company’s stock valued at $39,634,000 after purchasing an additional 41,730 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in Xylem by 2,309.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after purchasing an additional 413,904 shares in the last quarter. Callahan Advisors LLC bought a new position in Xylem in the fourth quarter worth approximately $1,721,000. Finally, Abacus Wealth Partners LLC purchased a new position in Xylem during the 4th quarter worth $1,663,000. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

Shares of XYL stock opened at $111.44 on Friday. The firm has a market cap of $26.49 billion, a price-to-earnings ratio of 27.72, a PEG ratio of 1.59 and a beta of 1.04. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The company’s 50 day moving average is $114.53 and its 200 day moving average is $126.30.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The company had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be given a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s payout ratio is presently 42.79%.

Xylem declared that its Board of Directors has initiated a share repurchase program on Wednesday, February 25th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the industrial products company to reacquire up to 4.8% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.

Analysts Set New Price Targets

A number of brokerages have weighed in on XYL. Barclays decreased their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research report on Wednesday, April 29th. Jefferies Financial Group reissued a “hold” rating and set a $130.00 price target (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. Weiss Ratings lowered Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. decreased their price objective on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Finally, Oppenheimer lowered their price objective on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Xylem has an average rating of “Moderate Buy” and an average target price of $152.77.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of Xylem stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jerome A. Peribere bought 1,210 shares of Xylem stock in a transaction on Monday, May 4th. The stock was purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.32% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.